ABBV

ABBV

USD

AbbVie Inc. Common Stock

$215.890+3.520 (1.657%)

Preço em tempo real

Healthcare
Drug Manufacturers - General
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$212.370

Máximo

$217.080

Mínimo

$212.370

Volume

6.49M

Fundamentos da empresa

Capitalização de mercado

381.4B

Setor

Drug Manufacturers - General

País

United States

Estatísticas de negociação

Volume médio

5.41M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $163.81Atual $215.890Máximo $244.81

Notícias relacionadas

Analyst Upgrades

Citigroup Maintains Neutral on AbbVie, Lowers Price Target to $235

Citigroup analyst Geoff Meacham maintains AbbVie with a Neutral and lowers the price target from $240 to $235.

Ver mais
Citigroup Maintains Neutral on AbbVie, Lowers Price Target to $235
Analyst Upgrades

JP Morgan Maintains Overweight on AbbVie, Raises Price Target to $260

JP Morgan analyst Chris Schott maintains AbbVie with a Overweight and raises the price target from $250 to $260.

Ver mais
JP Morgan Maintains Overweight on AbbVie, Raises Price Target to $260
Analyst Upgrades

AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend

AbbVie beats Q3 estimates with $15.78 billion revenue, boosts dividend to $1.73, raises earnings outlook on strong drug portfolio growth.

Ver mais
AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend
PR Newswire

AbbVie Reports Third-Quarter 2025 Financial Results

AbbVie (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2025. "AbbVie continues to deliver outstanding results, with ...

Ver mais
AbbVie Reports Third-Quarter 2025 Financial Results
PR Newswire

The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the seventh annual BOTOX® Cosmetic Day will take place on Wednesday, November...

Ver mais
The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year
PR Newswire

AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo

AbbVie (NYSE: ABBV) today announced positive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib...

CNBC

Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings

Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings this week.

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.